The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy-Reference-Cited by-同舟云学术

The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy

Published:2015-04 Issue:4 Volume:17 Page:292-298
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Bever Katherine M.,Sugar Elizabeth A.,Bigelow Elaine,Sharma Rajni,Laheru Daniel,Wolfgang Christopher L.,Jaffee Elizabeth M.,Anders Robert A.,De Jesus-Acosta Ana,Zheng Lei

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference16 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Pancreatic cancer: progress in cancer therapy;Pierantoni;Crit Rev Oncol Hematol,2008

3. The role of the tumour microenvironment in the progression of pancreatic cancer;Farrow;J Surg Res,2008

4. Pancreatic cancer: the role of pancreatic stellate cells in tumour progression;Duner;Pancreatology,2011

5. Stromal biology and therapy in pancreatic cancer;Neesse;Gut,2010

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology;Expert Opinion on Drug Delivery;2024-06-02

2. Prognostic significance of collagen signatures in pancreatic ductal adenocarcinoma obtained from second-harmonic generation imaging;BMC Cancer;2024-05-29

3. Feasibility and effectiveness of automatic deep learning network and radiomics models for differentiating tumor stroma ratio in pancreatic ductal adenocarcinoma;Insights into Imaging;2023-12-21

4. Intraoperative Imaging in Hepatopancreatobiliary Surgery;Cancers;2023-07-20

5. Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma;Nature Communications;2023-06-13